YAP/TAZ affects the development of pulmonary fibrosis by regulating multiple signaling pathways
- 19 August 2020
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 475 (1-2) , 137-149
Abstract
YAP and TAZ are important co-activators of various biological processes in human body. YAP/TAZ plays a vital role in the development of pulmonary fibrosis. Dysregulation of the YAP/TAZ signaling pathway is one of the most important causes of pulmonary fibrosis. Therefore, considering its crucial role, summary of the signal mechanism of YAP/TAZ is of certain guiding significance for the research of YAP/TAZ as a therapeutic target. The present review provided a detailed introduction to various YAP/TAZ-related signaling pathways and clarified the specific role of YAP/TAZ in these pathways. In the meantime, we summarized and evaluated possible applications of YAP/TAZ in the treatment of pulmonary fibrosis. Overall, our study is of guiding significance for future research on the functional mechanism of YAP/TAZ underlying lung diseases as well as for identification of novel therapeutic targets specific to pulmonary fibrosis.Keywords
Funding Information
- Zhejiang Provincial Science and Technology Projects (2018C3710)
- Medical Science and Technology Project of Zhejiang Province (2020KY321)
This publication has 126 references indexed in Scilit:
- Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPGenes & Development, 2012
- Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitmentProceedings of the National Academy of Sciences, 2012
- Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver diseaseNature Medicine, 2012
- Biophysical Analysis of Binding of WW Domains of the YAP2 Transcriptional Regulator to PPXY Motifs within WBP1 and WBP2 AdaptorsBiochemistry, 2011
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 LigaseJournal of Biological Chemistry, 2010
- The Hippo–YAP pathway in organ size control and tumorigenesis: an updated versionGenes & Development, 2010
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneCancer Cell, 2009
- Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth controlGenes & Development, 2007
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 ampliconProceedings of the National Academy of Sciences, 2006